|
and this
so it’s great to have
References: 1. Boniva® 150 mg tablets approved package insert, March 2009. 2. Department of Health. Database of Medicine Prices 14 Nov 2016. [Accessed 21 Nov 2016]. Available at: http://www.mpr.gov.za/PublishedDocumentsaspx#DocCatld=21. 3. Harris ST, Reginster J-Y, Harley C, et al. Risk of fracture in women
treated with monthly oral ibandronate or weekly bisphosphonates: The eValuation of IBandronate Efficacy (VIBE) database fracture study. Bone 2009;44:758-765. 4. Rossiter D (Ed). South African Medicines Formulary. 11th Ed. 2014. p278. 5. Miller PD, Recker RR, Harris S, et al. Long-term fracture rates seen with continued
ibandronate treatment: pooled analysis of DIVA and MOBILE long-term extension studies. Osteoporos Int 2014;25:349-357. 6. Miller PD, Recker RR, Reginster J-Y, et al. Efficacy of monthly oral ibandronate is sustained over 5 years: the MOBILE long-term extension study. Osteoporos Int 2012;23:1747-1756.